You are viewing the site in preview mode

Skip to main content

Table 2 Observation schedule

From: 6-mm vs 10-mm diameter fully covered self-expandable metal stents in patients with unresectable malignant distal bile duct stricture (COSMIC UNISON): study protocol for a multicenter, randomized controlled trial

 

Enrollment

Date of treatmenta

Observation period (months)

Endb

3

6

12

Informed consent

     

Eligibility screen

     

Allocation

 

    

Interventions

 6-mm diameter FCSEMS

 

    

 10-mm diameter FCSEMS

 

    

Assessments

 Patient background

     

 Type of immediate bile duct drainage

     

 Presence and severity of acute cholangitis

     

 Peripheral blood count and biochemical tests

     

 Details of bile duct stenting procedure, prophylaxis use, and surgeon experience in ERCP

 

    

 Time to RBO

     

 Clinical success

     

 Blood tests

  

Every 3 months, until RBO occurs

 Imaging studies

  

As needed

 Non-RBO rate

  

 

 Overall survival

     

 Presence of anti-tumor therapy

     

 Adverse events other than RBO

     

 Information on discontinuation

  

At any time

  1. ERCP endoscopic retrograde cholangiopancreatography, FCSEMS fully covered self-expandable metal stents, RBO recurrent biliary obstruction
  2. aWithin 14 days of enrollment
  3. bDate of RBO or study end (31 March 2029)